# Hilton Worldwide Holdings Inc.: financial statements, quarterly

HLT · NYSE · CIK 1585689 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hlt.md) · [Financials](/companies/hlt/financials.md) · [Filings](/companies/hlt/filings.md) · [Insiders](/companies/hlt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hlt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,609 d](/filings/0001585689-26-000007.md) | [2,573](/filings/0001585689-25-000089.md) | [2,951](/filings/0001585689-25-000145.md) | [2,867](/filings/0001585689-25-000160.md) | [2,783 d](/filings/0001585689-26-000007.md) | [2,695](/filings/0001585689-26-000032.md) | [3,137](/filings/0001585689-26-000043.md) | [3,120](/filings/0001585689-26-000054.md) | [3,087 d](/filings/0001585689-26-000007.md) | [2,937](/filings/0001585689-26-000032.md) | [3,341](/filings/0001585689-26-000043.md) | [3,325](/filings/0001585689-26-000054.md) |
| Operating income | $m | [400 d](/filings/0001585689-26-000007.md) | [533](/filings/0001585689-25-000089.md) | [725](/filings/0001585689-25-000145.md) | [623](/filings/0001585689-25-000160.md) | [489 d](/filings/0001585689-26-000007.md) | [536](/filings/0001585689-26-000032.md) | [778](/filings/0001585689-26-000043.md) | [777](/filings/0001585689-26-000054.md) | [602 d](/filings/0001585689-26-000007.md) | [678](/filings/0001585689-26-000032.md) | [858](/filings/0001585689-26-000043.md) | [909](/filings/0001585689-26-000054.md) |
| Interest expense | $m | [124 d](/filings/0001585689-25-000008.md) | [131](/filings/0001585689-24-000101.md) | [141](/filings/0001585689-24-000162.md) | [140](/filings/0001585689-24-000191.md) | [157 d](/filings/0001585689-25-000008.md) | [145](/filings/0001585689-26-000032.md) | [151](/filings/0001585689-26-000043.md) | [159](/filings/0001585689-26-000054.md) | [165 d](/filings/0001585689-26-000007.md) | [162](/filings/0001585689-26-000032.md) | [183](/filings/0001585689-26-000043.md) | [184](/filings/0001585689-26-000054.md) |
| Income tax | $m | [124 d](/filings/0001585689-26-000007.md) | [97.0](/filings/0001585689-25-000089.md) | [169](/filings/0001585689-25-000145.md) | [147](/filings/0001585689-25-000160.md) | [(169) d](/filings/0001585689-26-000007.md) | [110](/filings/0001585689-26-000032.md) | [187](/filings/0001585689-26-000043.md) | [183](/filings/0001585689-26-000054.md) | [131 d](/filings/0001585689-26-000007.md) | [135](/filings/0001585689-26-000032.md) | [198](/filings/0001585689-26-000043.md) | [186](/filings/0001585689-26-000054.md) |
| Net income | $m | [147 d](/filings/0001585689-26-000007.md) | [265](/filings/0001585689-25-000089.md) | [421](/filings/0001585689-25-000145.md) | [344](/filings/0001585689-25-000160.md) | [505 d](/filings/0001585689-26-000007.md) | [300](/filings/0001585689-26-000032.md) | [440](/filings/0001585689-26-000043.md) | [420](/filings/0001585689-26-000054.md) | [297 d](/filings/0001585689-26-000007.md) | [385](/filings/0001585689-26-000032.md) | [482](/filings/0001585689-26-000043.md) | [536](/filings/0001585689-26-000054.md) |
| Diluted EPS | $ per share | not reported | [1.04](/filings/0001585689-25-000089.md) | [1.67](/filings/0001585689-25-000145.md) | [1.38](/filings/0001585689-25-000160.md) | not reported | [1.23](/filings/0001585689-26-000032.md) | [1.84](/filings/0001585689-26-000043.md) | [1.78](/filings/0001585689-26-000054.md) | not reported | [1.66](/filings/0001585689-26-000032.md) | [2.10](/filings/0001585689-26-000043.md) | [2.37](/filings/0001585689-26-000054.md) |
| Basic EPS | $ per share | not reported | [1.05](/filings/0001585689-25-000089.md) | [1.69](/filings/0001585689-25-000145.md) | [1.40](/filings/0001585689-25-000160.md) | not reported | [1.25](/filings/0001585689-26-000032.md) | [1.85](/filings/0001585689-26-000043.md) | [1.79](/filings/0001585689-26-000054.md) | not reported | [1.68](/filings/0001585689-26-000032.md) | [2.12](/filings/0001585689-26-000043.md) | [2.39](/filings/0001585689-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0001585689-25-000008.md) | [1.3](/filings/0001585689-24-000101.md) | [0.7](/filings/0001585689-24-000162.md) | [1.6](/filings/0001585689-24-000191.md) | [1.3](/filings/0001585689-26-000007.md) | [0.7](/filings/0001585689-25-000089.md) | [0.4](/filings/0001585689-25-000145.md) | [1.1](/filings/0001585689-25-000160.md) | [0.9](/filings/0001585689-26-000054.md) | [0.6](/filings/0001585689-26-000032.md) | [1.0](/filings/0001585689-26-000043.md) | [0.8](/filings/0001585689-26-000054.md) |
| Current assets | $bn | [2.6](/filings/0001585689-25-000008.md) | [3.2](/filings/0001585689-24-000101.md) | [2.7](/filings/0001585689-24-000162.md) | [3.6](/filings/0001585689-24-000191.md) | [3.3](/filings/0001585689-26-000007.md) | [2.8](/filings/0001585689-25-000089.md) | [2.5](/filings/0001585689-25-000145.md) | [3.1](/filings/0001585689-25-000160.md) | [3.0](/filings/0001585689-26-000054.md) | [2.8](/filings/0001585689-26-000032.md) | [3.3](/filings/0001585689-26-000043.md) | [3.1](/filings/0001585689-26-000054.md) |
| Total assets | $bn | [15.4](/filings/0001585689-25-000008.md) | [15.9](/filings/0001585689-24-000101.md) | [15.7](/filings/0001585689-24-000162.md) | [16.7](/filings/0001585689-24-000191.md) | [16.5](/filings/0001585689-26-000007.md) | [16.0](/filings/0001585689-25-000089.md) | [15.9](/filings/0001585689-25-000145.md) | [16.6](/filings/0001585689-25-000160.md) | [16.8](/filings/0001585689-26-000054.md) | [16.4](/filings/0001585689-26-000032.md) | [16.9](/filings/0001585689-26-000043.md) | [16.8](/filings/0001585689-26-000054.md) |
| Current liabilities | $bn | [3.7](/filings/0001585689-25-000008.md) | [3.8](/filings/0001585689-24-000101.md) | [4.2](/filings/0001585689-24-000162.md) | [4.5](/filings/0001585689-24-000191.md) | [4.7](/filings/0001585689-26-000007.md) | [4.8](/filings/0001585689-25-000089.md) | [4.6](/filings/0001585689-25-000145.md) | [4.7](/filings/0001585689-25-000160.md) | [4.5](/filings/0001585689-26-000054.md) | [4.6](/filings/0001585689-26-000032.md) | [5.1](/filings/0001585689-26-000043.md) | [5.3](/filings/0001585689-26-000054.md) |
| Total liabilities | $bn | [17.7](/filings/0001585689-25-000008.md) | [18.7](/filings/0001585689-24-000101.md) | [18.8](/filings/0001585689-24-000162.md) | [20.1](/filings/0001585689-24-000191.md) | [20.2](/filings/0001585689-26-000007.md) | [20.4](/filings/0001585689-25-000089.md) | [20.5](/filings/0001585689-25-000145.md) | [21.5](/filings/0001585689-25-000160.md) | [22.1](/filings/0001585689-26-000054.md) | [22.3](/filings/0001585689-26-000032.md) | [23.2](/filings/0001585689-26-000043.md) | [23.4](/filings/0001585689-26-000054.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [(2.4)](/filings/0001585689-25-000008.md) | [(2.8)](/filings/0001585689-24-000101.md) | [(3.1)](/filings/0001585689-24-000162.md) | [(3.5)](/filings/0001585689-24-000191.md) | [(3.7)](/filings/0001585689-26-000007.md) | [(4.4)](/filings/0001585689-25-000089.md) | [(4.6)](/filings/0001585689-25-000145.md) | [(4.9)](/filings/0001585689-25-000160.md) | [(5.4)](/filings/0001585689-26-000054.md) | [(5.9)](/filings/0001585689-26-000032.md) | [(6.3)](/filings/0001585689-26-000043.md) | [(6.6)](/filings/0001585689-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [465 d](/filings/0001585689-26-000007.md) | [346](/filings/0001585689-25-000089.md) | [421 d](/filings/0001585689-25-000145.md) | [664 d](/filings/0001585689-25-000160.md) | [582 d](/filings/0001585689-26-000007.md) | [452](/filings/0001585689-26-000032.md) | [658 d](/filings/0001585689-26-000043.md) | [816 d](/filings/0001585689-26-000054.md) | [203 d](/filings/0001585689-26-000007.md) | [618](/filings/0001585689-26-000032.md) | [472 d](/filings/0001585689-26-000043.md) | [721 d](/filings/0001585689-26-000054.md) |
| Capital expenditure | $m | [42.0 d](/filings/0001585689-26-000007.md) | [16.0](/filings/0001585689-25-000089.md) | [15.0 d](/filings/0001585689-25-000145.md) | [17.0 d](/filings/0001585689-25-000160.md) | [48.0 d](/filings/0001585689-26-000007.md) | [19.0](/filings/0001585689-26-000032.md) | [23.0 d](/filings/0001585689-26-000043.md) | [29.0 d](/filings/0001585689-26-000054.md) | [30.0 d](/filings/0001585689-26-000007.md) | [9.0](/filings/0001585689-26-000032.md) | [12.0 d](/filings/0001585689-26-000043.md) | [32.0 d](/filings/0001585689-26-000054.md) |
| Dividends paid | $m | [38.0 d](/filings/0001585689-26-000007.md) | [39.0](/filings/0001585689-25-000089.md) | [37.0 d](/filings/0001585689-25-000145.md) | [37.0 d](/filings/0001585689-25-000160.md) | [37.0 d](/filings/0001585689-26-000007.md) | [37.0](/filings/0001585689-26-000032.md) | [36.0 d](/filings/0001585689-26-000043.md) | [35.0 d](/filings/0001585689-26-000054.md) | [35.0 d](/filings/0001585689-26-000007.md) | [35.0](/filings/0001585689-26-000032.md) | [34.0 d](/filings/0001585689-26-000043.md) | [34.0 d](/filings/0001585689-26-000054.md) |
| Share repurchases | $m | [743 d](/filings/0001585689-26-000007.md) | [666](/filings/0001585689-25-000089.md) | [736 d](/filings/0001585689-25-000145.md) | [725 d](/filings/0001585689-25-000160.md) | [766 d](/filings/0001585689-26-000007.md) | [875](/filings/0001585689-26-000032.md) | [769 d](/filings/0001585689-26-000043.md) | [759 d](/filings/0001585689-26-000054.md) | [779 d](/filings/0001585689-26-000007.md) | [821](/filings/0001585689-26-000032.md) | [966 d](/filings/0001585689-26-000043.md) | [846 d](/filings/0001585689-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [269](/filings/0001585689-24-000101.md) | [266](/filings/0001585689-24-000162.md) | [262](/filings/0001585689-24-000191.md) | [255](/filings/0001585689-25-000089.md) | [252](/filings/0001585689-25-000145.md) | [249](/filings/0001585689-25-000160.md) | [243](/filings/0001585689-26-000032.md) | [239](/filings/0001585689-26-000043.md) | [237](/filings/0001585689-26-000054.md) | [232](/filings/0001585689-26-000032.md) | [229](/filings/0001585689-26-000043.md) | [226](/filings/0001585689-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 222,504,355 at 2026-10-22, from the cover of the [10-Q filed 2026-10-27](/filings/0001585689-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 10:12 ET. No prices; not investment advice.